VeriSIM Life, a pioneer in AI-enabled R&D decision de-risking for drug development, proudly shares that its founder and CEO, Jo Varshney, has achieved the prestigious Gold Stevie Award in the healthcare category during the 20th annual Stevie Awards for Women in Business.
The Stevie Awards, recognizing outstanding women entrepreneurs, executives, and employees globally, received over 1,600 nominations across 100 categories this year. Varshney, honored as one of the seven finalists for the “Most Innovative Woman of the Year – Healthcare” award, has been commended for her leadership in leveraging artificial intelligence and machine learning to enhance the value of drug candidate intellectual property in the early stages of development.
Originally hailing from India, Varshney moved to the United States in 2010 to delve into studies in comparative oncology, genomics, and bioinformatics. Her journey commenced by addressing the challenges of transitioning drug candidates from the laboratory to clinical trials. Winning a hackathon with her innovative concept, she established VeriSIM Life, a company at the forefront of AI-enabled drug development.
Expressing her gratitude, Varshney remarked, “I am honored to receive the 2023 Gold Stevie Award alongside influential women in the global healthcare field. This accolade reflects the dedication of every woman contributing to innovation in the healthcare industry.”
